HEMOSTOD
HemostOD manufactures platelets on-demand from engineered stem cells.
HEMOSTOD
Social Links:
Industry:
Biotechnology Manufacturing
Founded:
2020-01-01
Address:
Lausanne, Vaud, Switzerland
Country:
Switzerland
Website Url:
http://www.hemostod.com
Total Employee:
1+
Status:
Active
Total Funding:
1.7 M CHF
Technology used in webpage:
Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS Person Schema Facebook Sharer
Similar Organizations
Alternative Plants
Hidden botanical treasures - active ingredients from rare medicinal plants made accessible by our plant stem cell technology
Batavia Biosciences
Batavia Biosciences focuses on accelerating the transition of biopharmaceutical product
Microdermis
Microdermis manufactures and markets skin care products for skin repair and protection, antimicrobial, and dental skin care.
Norman Biological Technology
Norman Biological Technology is a manufacturer of automated chemiluminescence system.
Current Employees Featured
Founder
Investors List
Orenok Holdings
Orenok Holdings investment in Seed Round - Hemostod
Official Site Inspections
http://www.hemostod.com
- Host name: 93.136.216.35.bc.googleusercontent.com
- IP address: 35.216.136.93
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
More informations about "Hemostod"
Hemostod - Crunchbase Company Profile & Funding
HemostOD has developed a process to engineer and manufacture platelets, providing a source of universal platelets through a scalable platform. CAR-PLT® Technology A technology for …See details»
HemostOD SA – Swiss Biotech
HemostOD manufactures blood platelets on demand, a life saving solution. HemostOD provides an alternative to blood donor platelet transfusions, to relieve blood banks and hospitals. ... Type of organization. Private company. Year of …See details»
HemostOD - LinkedIn
HemostOD Partners with Switzerland's Largest Blood Transfusion Service! Together, They are set to revolutionize platelet production through innovative in vitro methods, bringing transformative ...See details»
HemostOD SA - BioAlps
Avenue de Sécheron 15 1202 Geneva, Switzerland T +41 22 545 12 91. c/o BIOPÔLE SA Secteur Esplanade / Bâtiment Serine Route de la Corniche 8 1066 Epalinges, SwitzerlandSee details»
Archives - HemostOD
HemostOD receives a loan of CHF 100’000 from the Foundation for Technological Innovation (FIT). Seed Round. HemostOD raises CHF 1.7M in seed round financing. Venture Kick II. …See details»
HemostOD Company Profile 2024: Valuation, Funding & Investors
HemostOD General Information Description. Developer of ex vivo platelets intended to offer an efficient alternative to blood donor platelet transfusions. The company generates high …See details»
HemostOD - Products, Competitors, Financials, Employees, …
HemostOD is a preclinical biotech company focused on the engineering and manufacturing of platelets. Their main offerings include the production of universal platelets designed to be HLA …See details»
EPFL startup develops system for producing blood …
Jan 26, 2023 HemostOD’s device aims to replicate this process ex vivo so that platelets can be produced quickly and on a large scale in a laboratory. “In our system, a fluid containing megakaryocytes flows in a microfluidic device with …See details»
Hemostod - Contacts, Employees, Board Members, Advisors
HemostOD manufactures platelets on-demand from engineered stem cells.See details»
HemostOD SA | BIO-Europe
HemostOD is a preclinical stage company developing a therapeutic platform inspired by platelet biology, allowing: - The production of in-vitro platelets as an alternative to unsatisfactory blood …See details»
HemostOD relies on Swiss Biotech Center to pre-industrialize its ...
Mar 30, 2023 Based at the EPFL Innovation Park, HemostOD has developed a novel process for the rapid and large-scale production of blood platelet via an ex-vivo process. Thanks to this …See details»
Seed Round - HemostOD
HemostOD raises CHF 1.7M in seed round financing. HemostOD SA. EPFL Innovation Park – Bâtiment M. Rue des Jordils, 1A. 1025 St-Sulpice. Switzerland.See details»
HemostOD receives CHF 100,000 from FIT for its on-demand …
In May 2021, HemostOD closed its Seed fundraising for an amount of 650'000 Swiss Francs. The Tech Seed loan from FIT will enable the company to achieve its technical goals in its …See details»
HemostOD will make platelets on demand - IO
Jan 28, 2023 HemostOD. HemostOD came up with a solution to this: making platelets via stem cells. To do this, they use a device developed in-house that can mimic the physical production …See details»
HemostOD et Emissium obtiennent le soutient de la FIT
HemostOD produces platelets rapidly and on a large scale Every year, 8 million platelet concentrates are transfused worldwide. This demand is growing by 5% a year, and is likely to …See details»
Hemostod | EU-Startups
HemostOD manufactures platelets on-demand from engineered stem cells. Manufacturing blood platelets on demand, A life saving solution. Worldwide, 10 Million platelet concentrates are …See details»
HemostOD creates ex vivo blood platelets - BioAlps
Nov 19, 2024 The Tech Seed loan from FIT will enable the company to achieve its technical goals in its InnoSuisse project, co-financed by InnoSuisse and HemostOD. The two-year …See details»
HemostOD partners with the biggest transfusion service in …
HemostOD annonce un partenariat avec le plus grand service de transfusion sanguine de Suisse. La société suisse de biotechnologie préclinique HemostOD et Transfusion Interrégionale CRS, …See details»
Partnering with the Swiss Biotech Center – HemostOD
HemostOD partners with the Swiss Biotech Center to pre-industrialize its technology. Thanks to this new partnership HemostOD will benefit from solid expertise and state-of-the-art …See details»